1. Home
  2. NSPR vs OPXS Comparison

NSPR vs OPXS Comparison

Compare NSPR & OPXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • OPXS
  • Stock Information
  • Founded
  • NSPR 2005
  • OPXS 1987
  • Country
  • NSPR United States
  • OPXS United States
  • Employees
  • NSPR N/A
  • OPXS N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • OPXS Electronic Components
  • Sector
  • NSPR Health Care
  • OPXS Technology
  • Exchange
  • NSPR Nasdaq
  • OPXS Nasdaq
  • Market Cap
  • NSPR 74.8M
  • OPXS 75.8M
  • IPO Year
  • NSPR N/A
  • OPXS N/A
  • Fundamental
  • Price
  • NSPR $2.38
  • OPXS $10.40
  • Analyst Decision
  • NSPR Strong Buy
  • OPXS
  • Analyst Count
  • NSPR 2
  • OPXS 0
  • Target Price
  • NSPR $4.50
  • OPXS N/A
  • AVG Volume (30 Days)
  • NSPR 112.3K
  • OPXS 60.1K
  • Earning Date
  • NSPR 08-05-2025
  • OPXS 08-12-2025
  • Dividend Yield
  • NSPR N/A
  • OPXS N/A
  • EPS Growth
  • NSPR N/A
  • OPXS 23.32
  • EPS
  • NSPR N/A
  • OPXS 0.75
  • Revenue
  • NSPR $7,066,000.00
  • OPXS $39,481,000.00
  • Revenue This Year
  • NSPR $4.85
  • OPXS N/A
  • Revenue Next Year
  • NSPR $113.47
  • OPXS N/A
  • P/E Ratio
  • NSPR N/A
  • OPXS $13.87
  • Revenue Growth
  • NSPR 7.60
  • OPXS 21.00
  • 52 Week Low
  • NSPR $1.99
  • OPXS $5.36
  • 52 Week High
  • NSPR $3.80
  • OPXS $14.60
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 44.93
  • OPXS 41.02
  • Support Level
  • NSPR $2.35
  • OPXS $10.10
  • Resistance Level
  • NSPR $2.52
  • OPXS $11.07
  • Average True Range (ATR)
  • NSPR 0.14
  • OPXS 1.00
  • MACD
  • NSPR -0.02
  • OPXS -0.29
  • Stochastic Oscillator
  • NSPR 7.50
  • OPXS 7.69

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About OPXS Optex Systems Holdings Inc.

Optex Systems Holdings Inc manufactures optical sighting systems and assemblies for the U.S. Department of Defense, foreign military applications, and commercial markets. Its products are installed on a variety of United States military land vehicles, such as the Abrams and Bradley fighting vehicles, and light armored and security vehicles, and have been selected for installation on the Stryker family of vehicles. The company's operating segment includes Optex Systems Richardson and Applied Optics Center Dallas and others. It generates maximum revenue from the Optex Systems Richardson segment. Some of its products include M17 Day/Thermal Periscope; DDAN / M36 Sights; Laser Protected Periscopes; Muzzle Reference Sensor and others.

Share on Social Networks: